CRISPR-Cas13a Targeting the FGFR3-TACC3 Fusion Gene Inhibits Proliferation of Bladder Cancer Cells in vitro and in vivo

Press/Media

Period	18 Dec 2024

Media coverage

Title	CRISPR-Cas13a Targeting the FGFR3-TACC3 Fusion Gene Inhibits Proliferation of Bladder Cancer Cells in vitro and in vivo
Media name/outlet	Dove Medical Press
Country/Territory	United Kingdom
Date	18/12/24
URL	ct.moreover.com/?a=55575279010&p=1gw&v=1&x=0835nFn7L1UpzmsuR-WyNQ
Persons	Matthew Bradley